Mesenchymal Stem Cell-Derived Antimicrobial Peptides As Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2022 Jul 25

PMID 35874827

Authors

Kasra Moeinabadi-Bidgoli

Malihe Rezaee

Hamidreza Rismanchi

Mohaddese Malek Mohammadi

Amirhesam Babajani

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSCs), as adult multipotent cells, possess considerable regenerative and anti-neoplastic effects, from inducing apoptosis in the cancer cells to reducing multidrug resistance that bring them up as an appropriate alternative for cancer treatment. These cells can alter the behavior of cancer cells, the condition of the tumor microenvironment, and the activity of immune cells that result in tumor regression. It has been observed that during inflammatory conditions, a well-known feature of the tumor microenvironment, the MSCs produce and release some molecules called "antimicrobial peptides (AMPs)" with demonstrated anti-neoplastic effects. These peptides have remarkable targeted anticancer effects by attaching to the negatively charged membrane of neoplastic cells, disrupting the membrane, and interfering with intracellular pathways. Therefore, AMPs could be considered as a part of the wide-ranging anti-neoplastic effects of MSCs. This review focuses on the possible anti-neoplastic effects of MSCs-derived AMPs and their mechanisms. It also discusses preconditioning approaches and using exosomes to enhance AMP production and delivery from MSCs to cancer cells. Besides, the clinical administration of MSCs-derived AMPs, along with their challenges in clinical practice, were debated.

Citing Articles

Preclinical Evaluation of the Safety, Toxicity and Efficacy of Genetically Modified Wharton's Jelly Mesenchymal Stem/Stromal Cells Expressing the Antimicrobial Peptide SE-33.

Gasanov V, Kashirskikh D, Khotina V, Kuzmina D, Nikitochkina S, Mukhina I Cells. 2025; 14(5).

PMID: 40072070 PMC: 11898551. DOI: 10.3390/cells14050341.

Beyond antibiotics: mesenchymal stem cells and bacteriophages-new approaches to combat bacterial resistance in wound infections.

Teymouri S, Yousefi M, Heidari S, Farokhi S, Afkhami H, Kashfi M Mol Biol Rep. 2024; 52(1):64.

PMID: 39699690 DOI: 10.1007/s11033-024-10163-x.

Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells.

Babajani A, Eftekharinasab A, Bekeschus S, Mehdian H, Vakhshiteh F, Madjd Z Cancer Cell Int. 2024; 24(1):344.

PMID: 39438918 PMC: 11515683. DOI: 10.1186/s12935-024-03523-x.

Nanomedicine in Neuroprotection, Neuroregeneration, and Blood-Brain Barrier Modulation: A Narrative Review.

Krsek A, Jagodic A, Baticic L Medicina (Kaunas). 2024; 60(9).

PMID: 39336425 PMC: 11433843. DOI: 10.3390/medicina60091384.

Nisin-preconditioned mesenchymal stem cells combatting nosocomial infections.

Enayati S, Halabian R, Saffarian P, Aghamollaei H, Saeedi P Regen Ther. 2024; 26:161-169.

PMID: 38911027 PMC: 11192785. DOI: 10.1016/j.reth.2024.05.015.

References

Melo M, Ferre R, Feliu L, Bardaji E, Planas M, Castanho M . Prediction of antibacterial activity from physicochemical properties of antimicrobial peptides. PLoS One. 2011; 6(12):e28549. PMC: 3237455. DOI: 10.1371/journal.pone.0028549. View

Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F . Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008; 15(10):730-8. DOI: 10.1038/gt.2008.39. View

Lo Y, Lee H, Tu W . The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells. Int J Mol Sci. 2015; 16(9):22711-34. PMC: 4613332. DOI: 10.3390/ijms160922711. View

Ye Z, Huang Y, Ke J, Zhu X, Leng S, Luo H . Breakthrough in targeted therapy for non-small cell lung cancer. Biomed Pharmacother. 2020; 133:111079. DOI: 10.1016/j.biopha.2020.111079. View

Lai Y, Gallo R . AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009; 30(3):131-41. PMC: 2765035. DOI: 10.1016/j.it.2008.12.003. View

Jiang R, Lonnerdal B . Bovine lactoferrin and lactoferricin exert antitumor activities on human colorectal cancer cells (HT-29) by activating various signaling pathways. Biochem Cell Biol. 2017; 95(1):99-109. DOI: 10.1139/bcb-2016-0094. View

Gardy J, Lynn D, Brinkman F, Hancock R . Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol. 2009; 30(6):249-62. DOI: 10.1016/j.it.2009.03.009. View

Divyashree M, Mani M, Reddy D, Kumavath R, Ghosh P, Azevedo V . Clinical Applications of Antimicrobial Peptides (AMPs): Where do we Stand Now?. Protein Pept Lett. 2019; 27(2):120-134. DOI: 10.2174/0929866526666190925152957. View

Qin Z, Blankenstein T . CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells. Immunity. 2000; 12(6):677-86. DOI: 10.1016/s1074-7613(00)80218-6. View

10.

Lee G, Kim T . pH-Responsive i-motif Conjugated Hyaluronic Acid/Polyethylenimine Complexes for Drug Delivery Systems. Pharmaceutics. 2019; 11(5). PMC: 6572266. DOI: 10.3390/pharmaceutics11050247. View

11.

Seo S, Kim K, Park S, Suh Y, Kim S, Jeun S . The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther. 2011; 18(5):488-95. PMC: 3125103. DOI: 10.1038/gt.2010.170. View

12.

Guzman-Rodriguez J, Lopez-Gomez R, Salgado-Garciglia R, Ochoa-Zarzosa A, Lopez-Meza J . The defensin from avocado (Persea americana var. drymifolia) PaDef induces apoptosis in the human breast cancer cell line MCF-7. Biomed Pharmacother. 2016; 82:620-7. DOI: 10.1016/j.biopha.2016.05.048. View

13.

Cheng L, Xing H, Mao X, Li L, Li X, Li Q . Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model. Scand J Immunol. 2014; 81(1):31-8. DOI: 10.1111/sji.12245. View

14.

Lei J, Sun L, Huang S, Zhu C, Li P, He J . The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019; 11(7):3919-3931. PMC: 6684887. View

15.

Nolsoe A, Jensen C, Ostergren P, Fode M . Neglected side effects to curative prostate cancer treatments. Int J Impot Res. 2020; 33(4):428-438. DOI: 10.1038/s41443-020-00386-4. View

16.

Hanaoka Y, Yamaguchi Y, Yamamoto H, Ishii M, Nagase T, Kurihara H . In Vitro and In Vivo Anticancer Activity of Human β-Defensin-3 and Its Mouse Homolog. Anticancer Res. 2016; 36(11):5999-6004. DOI: 10.21873/anticanres.11188. View

17.

Harman R, Yang S, He M, Van de Walle G . Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds. Stem Cell Res Ther. 2017; 8(1):157. PMC: 5496374. DOI: 10.1186/s13287-017-0610-6. View

18.

Rajabi M, Mousa S . The Role of Angiogenesis in Cancer Treatment. Biomedicines. 2017; 5(2). PMC: 5489820. DOI: 10.3390/biomedicines5020034. View

19.

Hu Q, Su H, Li J, Lyon C, Tang W, Wan M . Clinical applications of exosome membrane proteins. Precis Clin Med. 2020; 3(1):54-66. PMC: 7099650. DOI: 10.1093/pcmedi/pbaa007. View

20.

Shafiq M, Jung Y, Kim S . Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair. Biomaterials. 2016; 90:85-115. DOI: 10.1016/j.biomaterials.2016.03.020. View